Adverse events in patients with ankylosing spondylitis treated with TNF inhibitors: a cross-sectional study.

ABSTRACT: Background Although TNF inhibitors are well established in ankylosing spondylitis treatment, the majority of studies on TNF inhibitors safety have been performed in rheumatoid arthritis patients. Meanwhile, it seems that TNF inhibitors in ankylosing spondylitis may present a better safety profile than we thought. Objective The aim of our study was to retrospectively investigate the occurrence of adverse events in ankylosing spondylitis patients treated with TNF inhibitors. Setting A single referral center in Poland. Methods Detailed medical history of ankylosing spondylitis patients was obtained during the interview with the patient and by reviewing electronic medical records. Patients treated with TNF inhibitors and patients without TNF inhibitors treatment were compared. Main outcome mea

SUBMITTER: Wronski J 

PROVIDER: S-EPMC6677866 | biostudies-literature | 2019 Aug

REPOSITORIES: biostudies-literature